diacetylrhein

Known as: diacerhein, 2-Anthracenecarboxylic acid, 4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-, diacerein 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
OBJECTIVE To compare the effects of glucosamine (GlcN), curcumin, and diacerein in immortalized human C-28/I2 chondrocytes at the… (More)
Is this relevant?
2007
2007
OBJECTIVE To determine whether the efficacy of diacerein persists at 2 months after the end of a 3-month treatment period… (More)
Is this relevant?
2006
2006
Chondroprotective agents (CPA) such as glucosamine, curcumin and diacerein represent potential remedies for the management of… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2006
2006
OBJECTIVE To determine whether systemic markers of bone, cartilage, and synovium can predict structural progression of… (More)
Is this relevant?
2005
2005
In this study we analyzed the systemic antiallodynic properties of diacerhein, a drug used to treat osteoarthritis, in… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
OBJECTIVE To evaluate the ability of diacerein, an interleukin-1beta inhibitor, to slow the progressive decrease in joint space… (More)
Is this relevant?
2000
2000
In a double-blind, randomized, multicentre clinical study, the efficacy and tolerance of a herbal medicine product, Harpadol (6… (More)
Is this relevant?
1999
1999
OBJECTIVE To determine if diacerhein protects against the early stages of joint damage in a canine model of osteoarthritis (OA… (More)
Is this relevant?
1999
1999
The effects of several drugs (terfenadine, bradykinin B2 receptor antagonists: HOE 140, NPC 17731, diacerein, indomethacin… (More)
Is this relevant?
1994
1994
OBJECTIVE To determine the efficacy and safety of diacerhein, a potential new therapeutic agent with properties differing from… (More)
Is this relevant?